No Data
Tianshui Zhongxing Bio-technology (002772.SZ): has repurchased a total of 2.022% of its shares.
Gelonghui reported on December 18 that Tianshui Zhongxing Bio-technology (002772.SZ) announced that as of December 18, 2024, the company has repurchased a total of 7,951,326 shares through a special repurchase securities account via centralized bidding transactions, accounting for 2.0220% of the company's total equity. The highest Fill Price was 8.00 yuan/share, the lowest Fill Price was 7.34 yuan/share, and the total amount paid was 61.2229 million yuan (excluding transaction fees, etc.).
Tianshui Zhongxing Bio-Technology (002772.SZ): Signed an investment promotion contract with the Lianshui County People's Government. The total project investment is 0.55 billion yuan.
On November 26, Gelonghui reported that tianshui zhongxing bio-technology (002772.SZ) announced that based on the company's global strategy of "rooted in the northwest, facing the whole country, and moving towards the world" for its production base layout, as well as the planting variety development strategy of "focusing on enoki mushrooms and button mushrooms, with multi-variety collaborative development," to further consolidate and enhance the market share of the company's button mushroom products, the company intends to sign an "investment attraction contract" with the Lianshui County People's Government, and plans to invest in the establishment of a wholly-owned subsidiary, jiangsu tianshui zhongxing bio-technology technology Co., Ltd. (tentative name, subject to the information registered by market supervision and management departments) to construct and implement the "Lianshui edible mushroom industry.
Tianshui Zhongxing Bio-technology Plans Up to 150-Million-Yuan Share Buyback
Earnings Troubles May Signal Larger Issues for Tianshui Zhongxing Bio-technologyLtd (SZSE:002772) Shareholders
Zhongxing Bacteria: Report for the third quarter of 2024
tianshui zhongxing bio-technology (002772.SZ) released performance for the first three quarters, with a net income of 88.65 million yuan, a year-on-year decrease of 49.49%.
tianshui zhongxing bio-technology (002772.SZ) disclosed the third quarter report of 2024, achieving revenue in the first three quarters of 14...
Benign Growth For Tianshui Zhongxing Bio-technology Co.,Ltd. (SZSE:002772) Underpins Stock's 25% Plummet
